PMC:7283670 / 99250-101614 JSONTXT 9 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T858 0-278 Sentence denotes Various combination of protease inhibitors, oseltamivir, favipiravir, and chloroquin for treatment of covid19: a randomized control trial Drug: oral Thailand, coronavirus infections COVID19 80, all, 16–100 Treatment Experimental: oseltamivir plus chloroquin in mild COVID19
T859 279-354 Sentence denotes Oseltamivir 300 mg per day plus chloroquin 1,000 mg per Day In mild COVID19
T860 355-409 Sentence denotes Experimental: lopinavir and ritonavir plus favipiravir
T861 410-586 Sentence denotes Lopinavir 10 mg/kg and ritonavir 2.5 mg/kg plus favipiravir 2,400 mg, 2,400 mg, and 1,200 mg every 8 hr on Day 1, and a maintenance dose of 1,200 mg twice a day in Mild COVID19
T862 587-657 Sentence denotes Experimental: lopinavir and ritonavir plus oseltamivir in mild COVID19
T863 658-745 Sentence denotes Lopipinavir 10 mg/kg and ritonavir 2.5 mg/kg plus oseltamivir 4–6 mg/kg In mild COVID19
T864 746-822 Sentence denotes Experimental: lopinavir and ritonavir oseltamivir moderate to severe COVID19
T865 823-932 Sentence denotes Lopipinavir 10 mg/kg and ritonavir 2.5 mg/kg plus oseltamivir 4–6 mg/kg in moderate to critically ill COVID19
T866 933-987 Sentence denotes Experimental: favipiravir lopinavir/ritonavir for mod.
T867 988-997 Sentence denotes To severe
T868 998-1198 Sentence denotes favipiravir 2,400 mg, 2,400 mg, and 1,200 mg every 8 hr on Day 1, and a maintenance dose of 1,200 mg twice a day plus lopipinavir 10 mg/kg and ritonavir 2.5 mg/kg in moderate to critically ill COVID19
T869 1199-1267 Sentence denotes Experimental: darunavir/ritonavir oseltamivir chloroquine mod‐severe
T870 1268-1437 Sentence denotes Combination of Darunavir 400 mg every 8 hr ritonavir Ritonavir 2.5 mg/kg plus Oseltamivir 4–6 mg/kg plus Chloroquine 500 mg per Day In moderate to critically ill COVID19
T871 1438-1506 Sentence denotes Experimental: darunavir/ritonavir favipiravir chloroquine mod‐severe
T872 1507-1752 Sentence denotes Favipiravir 2,400 mg, 2,400 mg, and 1,200 mg every 8 hr on Day 1, and a maintenance dose of 1,200 mg twice a day plus darunavir 400 mg every 8 hr ritonavir ritonavir 2.5 mg/kg plus chloroquine 500 mg per Day In moderate to critically ill COVID19
T873 1753-1792 Sentence denotes No intervention: conventional qurantine
T874 1793-1901 Sentence denotes Patient who unwilling to treatment and willing to quarantine in mild COVID19 III Primary (Up to 24 weeks):
T875 1902-1929 Sentence denotes SARS‐CoV‐2 eradication time
T876 1930-1957 Sentence denotes Secondary (up to 24 weeks):
T877 1958-2222 Sentence denotes Number of patient with death, number of patient with recovery adjusted by initial severity in each arm, number of day with ventilator dependent adjusted by initial severity in each arm,number of patient developed acute respiratory distress syndrome after treatment
T878 2223-2246 Sentence denotes Other (up to 24 weeks):
T879 2247-2364 Sentence denotes Number of patient with acute respiratory distress syndrome recovery NCT04303299/Not yet recruiting, Mar15‐Nov30 2020